Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. canada alberta
  4. inflammatory agent
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Inflammatory Agent Articles & Analysis

7 news found

Alfa Chemistry Expands Portfolio with Diverse Alkaloids-Related Natural Products for Health, Nutrition Enhancement

Alfa Chemistry Expands Portfolio with Diverse Alkaloids-Related Natural Products for Health, Nutrition Enhancement

Alfa Chemistry, a recognized leader in the alkaloid industry, has expanded its offerings to include a comprehensive range of alkaloids-related natural products. This expansion underscores its commitment to providing high-quality compounds for various applications in medicine, food, and cosmetics. The suite of products now includes saccharides, flavonoids, terpenoids, phenylpropanoids, ...

ByAlfa Chemistry


XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease

XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease

XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report a significant potential market opportunity for its oral dissolvable (“ODF”) biosensor screening tests for oral inflammation. Certain buprenorphine medicines prescribed to treat opioid use disorder (“OUD”) and pain have been recently associated ...

ByXPhyto Therapeutics Corporation


XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business Opportunities

XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business Opportunities

XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report that it has signed a non-binding Letter of Intent (“LOI”) to identify and assess potential business synergies for manufacturing, import/export, distribution and product development with a US-based thin film manufacturing firm (the “Firm”). ...

ByXPhyto Therapeutics Corporation


Gesynta Pharma reports positive Phase I results with lead candidate GS-248 for microvascular disease at EULAR 2020

Gesynta Pharma reports positive Phase I results with lead candidate GS-248 for microvascular disease at EULAR 2020

Gesynta Pharma AB ("Gesynta"), a clinical stage company developing novel anti-inflammatory agents, today announced that the results from the successfully completed First-in-Human clinical study with its lead candidate GS-248 for the treatment of microvascular disease have been presented at the EULAR 2020 E-Congress. Following these results, Gesynta now intends to commence a Phase II study in ...

ByGesynta Pharma AB


TISSIUM Awarded 2.2M€ from i-Nov Competition to Address Chronic Rhinosinusitis

TISSIUM Awarded 2.2M€ from i-Nov Competition to Address Chronic Rhinosinusitis

TISSIUM, a privately-owned life science company developing fullysynthetic, biomorphic programmable polymers, announced today it has been awarded 2.2M€ in financing that will accelerate its development of a drug-eluting tissue adhesive to address the unmet needs of Chronic Rhinosinusitis (CRS) patients. The funding comes from the Investments for the Future program (Programme ...

ByTISSIUM


This year`s Medical Innovation Summit will highlight neurosciences innovation

This year`s Medical Innovation Summit will highlight neurosciences innovation

Thousands of researchers, investors, entrepreneurs and those who are simply curious will descend upon the Cleveland Convocation Center October 26-28 for Cleveland Clinic Innovations Medical Innovation Summit. This year’s theme, The Neurosciences: Memory. Mood. Movement, will cover all aspects of the human brain and how it functions and malfunctions. “This is our marquee event,” ...

ByInfuseon Therapeutics Inc


Asbestos Exposure Linked to Increased Risk of Stroke, Cardiovascular Disease

Asbestos Exposure Linked to Increased Risk of Stroke, Cardiovascular Disease

As a health risk, asbestos is most commonly linked to mesothelioma, lung cancer, and asbestosis, as well as a handful of other respiratory issues. However, a recent study published by Britain’s Journal of Occupational and Environmental Medicine has also linked asbestos exposure to an increased risk of stroke and cardiovascular disease due to its inflammatory properties. The study included ...

ByEMSL Analytical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT